Results 171 to 180 of about 98,167 (262)

An Aberrant Right Colic Artery Arising From the Right Gastroepiploic Artery

ANZ Journal of Surgery, EarlyView.
George Triantafyllou, Ioannis Paschopoulos, George Tsakotos, Orestis Lyros, Panagiotis Kokoropoulos, Maria Piagkou   +5 more
wiley   +1 more source

Re‐thinking peripheral dysfunctions in obesity: The emerging role of sulphaceutics and sulphanutraceutics

British Journal of Pharmacology, EarlyView.
Obesity is a chronic, relapsing, multisystem disease in which cardiometabolic risk arises from excess adiposity and progressive dysfunction of peripheral organs, ultimately disrupting endocrine and metabolic crosstalk among tissues. Within this network, sulphur‐based biology, centred on hydrogen sulphide and related reactive sulphur species, has ...
Martina Smimmo, Veronica Casale, Roberta d'Emmanuele di Villa Bianca, Valentina Vellecco, Mariarosaria Bucci   +4 more
wiley   +1 more source

Large vessel vasculopathy: An underrecognized complication in Wiskott-Aldrich syndrome. [PDF]

J Hum Immun
Suri D, Nadig PL, Desai D, Sharma Y, Jamal A, Vaitheeswaran GC, Choudhary H, Sudhakar M, Aggarwal R, Basu S, Suku P, Joshi V, Rikhi R, Bhatia A, Saxena A, Singhal M, Dhaliwal M, Sharma S, Pilania RK, Jindal AK, Pandiarajan V, Rawat A, Gupta A, Singh S.   +23 more
europepmc   +1 more source

The role of macrophage migration inhibitory factor (MIF) in the pathogenesis and progression of cardiovascular disease

British Journal of Pharmacology, EarlyView.
Abstract Cardiovascular disease (CVD) remains the leading global cause of death, driven by complex mechanisms, in which chronic inflammation plays a central role. Inflammatory pathways contribute to all stages of CVD, from endothelial dysfunction and plaque formation to erosion, rupture and myocardial injury.
Shreya Mahabhashyam, James Harris, Jürgen Bernhagen, Antony Vinh, Katrina M. Mirabito Colafella   +4 more
wiley   +1 more source

The influence of lean and fat mass on vascular structure and function in youth of varying body mass index percentiles- a comprehensive approach. [PDF]

Front Endocrinol (Lausanne)
Evanoff NG, Dooley JS, Kelly AS, Dengel DR.   +3 more
europepmc   +1 more source

Transcriptomic and metabolomic analyses reveal that lobeglitazone ameliorates hepatic steatosis in rats concurrent with regulation of mitochondrial pyruvate metabolism

British Journal of Pharmacology, EarlyView.
Background and Purpose Lobeglitazone is a thiazolidinedione and PPARγ agonist that improves metabolic parameters and hepatic steatosis, but its mechanisms are not fully understood. This study investigated the effects of lobeglitazone on hepatic transcriptomic and metabolic profiles in a rat model of obesity and Type 2 diabetes mellitus.
Hyekyung Yang, Su Young Son, Youngmi Song, Hyewon Choi, In‐Gu Do, Choong Hwan Lee, Cheol‐Young Park   +6 more
wiley   +1 more source

Intravascular lithotripsy for coral reef aortic stenosis: a case series assessing feasibility, hemodynamic effects, imaging and clinical outcomes. [PDF]

CVIR Endovasc
Dimopoulos MP, Papageorgiou M, Nistikoulis G, Kitrou P, Karnabatidis D, Katsanos K.   +5 more
europepmc   +1 more source

Abdominal Aorta [PDF]

, 2020
openaire   +1 more source

Targeting PCSK9 in Vascular Smooth Muscle Cells: An Effective Strategy to Suppress Ferroptosis and Attenuate Abdominal Aortic Aneurysm Progression

Cell Proliferation, EarlyView.
PCSK9 aggravates AAA by promoting ferroptosis in VSMCs. In the pathological AAA environment, PCSK9 upregulation triggers ferritinophagy‐dependent degradation of FTH1, leading to Fe2+ release, triggering lipid peroxidation and ferroptosis, exacerbating AAA.
Mengdie Xia, Man Li, Yanyu Chen, Jialin Chen, Yuting Cui, Xi‐Long Zheng, Jing Yang, Bingzhao Li, Xiaofeng Ma, Miao Liu, Gang Fan, Juan Peng, Xiaoyan Dai, Zhihan Tang   +13 more
wiley   +1 more source